These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 22210352)
21. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy. Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407 [TBL] [Abstract][Full Text] [Related]
22. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells. Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110 [TBL] [Abstract][Full Text] [Related]
23. Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase. Xu J; Arnér ES Biochem Pharmacol; 2012 Mar; 83(6):815-20. PubMed ID: 22226931 [TBL] [Abstract][Full Text] [Related]
24. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494 [TBL] [Abstract][Full Text] [Related]
25. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity. Zheng X; Ma W; Sun R; Yin H; Lin F; Liu Y; Xu W; Zeng H Redox Biol; 2018 Apr; 14():237-249. PubMed ID: 28965082 [TBL] [Abstract][Full Text] [Related]
26. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase. Peng X; Xu J; Arnér ES Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015 [TBL] [Abstract][Full Text] [Related]
27. Why is mammalian thioredoxin reductase 1 so dependent upon the use of selenium? Lothrop AP; Snider GW; Ruggles EL; Hondal RJ Biochemistry; 2014 Jan; 53(3):554-65. PubMed ID: 24393022 [TBL] [Abstract][Full Text] [Related]
28. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation. Zheng X; Zhang Y; Zhang L; Xu W; Ma W; Sun R; Zeng H Biomed Pharmacother; 2016 Oct; 83():212-220. PubMed ID: 27372405 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo. Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048 [TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of ethaselen and selenite treatment against A549 human non-small cell lung cancer cells. Xu W; Ma WW; Zeng HH Asian Pac J Cancer Prev; 2014; 15(17):7129-35. PubMed ID: 25227802 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds. Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine as an irreversible inhibitor of mammalian thioredoxin reductase1. Chen W; Jiang Z; Lin N; Zheng Z; Chen Z; Zhang X; Guan X J Enzyme Inhib Med Chem; 2016; 31(2):229-35. PubMed ID: 25778746 [TBL] [Abstract][Full Text] [Related]
34. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase. Duan D; Zhang B; Yao J; Liu Y; Sun J; Ge C; Peng S; Fang J Free Radic Biol Med; 2014 Apr; 69():15-25. PubMed ID: 24407164 [TBL] [Abstract][Full Text] [Related]
35. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1. Cheng Q; Sandalova T; Lindqvist Y; Arnér ES J Biol Chem; 2009 Feb; 284(6):3998-4008. PubMed ID: 19054767 [TBL] [Abstract][Full Text] [Related]
36. Investigation of the effects of thiazole compounds on thioredoxin reductase 1 (TrxR1), glutathione S-transferase (GST), and glutathione reductase (GR) targeted human brain glioblastoma cancer (U-87 MG). Korkmaz IN Biotechnol Appl Biochem; 2024 Aug; 71(4):948-959. PubMed ID: 38682343 [TBL] [Abstract][Full Text] [Related]
37. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase. Peng X; Zhang MQ; Conserva F; Hosny G; Selivanova G; Bykov VJ; Arnér ES; Wiman KG Cell Death Dis; 2013 Oct; 4(10):e881. PubMed ID: 24157875 [TBL] [Abstract][Full Text] [Related]
38. TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Cebula M; Schmidt EE; Arnér ES Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897 [TBL] [Abstract][Full Text] [Related]
39. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway. Lan L; Zhao F; Wang Y; Zeng H Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300 [TBL] [Abstract][Full Text] [Related]
40. Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines. Liao J; Wang L; Wu Z; Wang Z; Chen J; Zhong Y; Jiang F; Lu Y J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1158-1163. PubMed ID: 31179772 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]